Share
CNBC Pro

Watch CNBC's full interview with Pfizer CEO Albert Bourla

Pfizer CEO Albert Bourla sits down with CNBC's Meg Tirrell and the 'Squawk Box' team to discuss the company's plans to develop a new vaccine to target the worrisome omicron coronavirus variant. Bourla also discusses the pharma giant's oral antiviral pill under development, known as Paxlovid. Pfizer now expects to make 80 million treatment courses of the pill, up from a previously estimated 50 million.
14:48
Mon, Nov 29 202110:44 AM EST

watch now
VIDEO09:19
CNBC ProWells Fargo, Coinbase, and Google are some of today's top picks: Pro Market Movers Jan. 14
watch now
VIDEO07:32
CNBC ProWatch CNBC's full interview with David Rosenberg, Rosenberg Research
watch now
VIDEO06:17
CNBC ProWatch CNBC's full interview with Wells Fargo CFO, after beating Q4 earnings estimates
watch now
VIDEO03:55
CNBC ProWatch CNBC's full interview with Christopher Marinac of Janney Montgomery Scott
watch now
VIDEO43:48
CNBC ProWatch Friday's full episode of the Halftime Report — January 14, 2022